Drawing on this, single cell and mechanistic studies in prostate cancer highlight and AR+/TREM2+ inhibitory TAM state that becomes more prevalent in mPCa, and particularly in bone metastases. The gene discussed is TREM2; the disease is Familial prostate cancer.